Treating Hereditary Rare Diseases With In Vivo Precision Genetic Medicines (THRIVE)

Location: District of Columbia
Posted: Sep 25, 2025
Due: Sep 30, 2025
Agency: HEALTH AND HUMAN SERVICES, DEPARTMENT OF
Type of Government: Federal
Category:
  • A - Research and development
Solicitation No: ARPA-H-SN-25-131
Publication URL: To access bid details, please log in.
Follow
Treating Hereditary Rare Diseases With In Vivo Precision Genetic Medicines (THRIVE)
Active
Contract Opportunity
Notice ID
ARPA-H-SN-25-131
Related Notice
Department/Ind. Agency
HEALTH AND HUMAN SERVICES, DEPARTMENT OF
Sub-tier
NATIONAL INSTITUTES OF HEALTH
Office
ADVANCED RESEARCH PROJECTS AGENCY FOR HEALTH (ARPA-H)
General Information
  • Contract Opportunity Type: Special Notice (Original)
  • Original Published Date: Sep 25, 2025 09:02 am EDT
  • Original Response Date: Sep 30, 2025 11:59 pm EDT
  • Inactive Policy: 15 days after response date
  • Original Inactive Date: Oct 15, 2025
  • Initiative:
    • None
Classification
  • Original Set Aside: No Set aside used
  • Product Service Code: AN13 - HEALTH R&D SERVICES; HEALTH CARE SERVICES; EXPERIMENTAL DEVELOPMENT
  • NAICS Code:
    • 541714 - Research and Development in Biotechnology (except Nanobiotechnology)
  • Place of Performance:
    Washington , DC 20005
    USA
Description

This Special Notice (SN) is intended to alert the scientific community to a newly approved ARPA-H Program and notify potential proposers of an associated Proposers’ Day (PD). Under the cognizance of HSF, ARPA-H is publishing an Innovative Solutions Opening (ISO) for the Treating Hereditary Rare diseases with In Vivo precision genetic mEdicines (THRIVE) program no later than September 25, 2025, please monitor SAM.gov for updates (ARPA-H-SOL-25-122).



For additional PD details and registration information see the attached special notice (ARPA-H-SN-25-131).



For more information about the THRIVE program visit: https://arpa-h.gov/explore-funding/programs/thrive


Attachments/Links
Contact Information
Contracting Office Address
  • 1301 K Street NW Suite 1200 West
  • Washington , DC 20005
  • USA
Primary Point of Contact
Secondary Point of Contact


History

Related Document

Oct 1, 2025[Special Notice (Updated)] Treating Hereditary Rare Diseases With In Vivo Precision Genetic Medicines (THRIVE)
Daily notification on new contract opportunities

With GovernmentContracts, you can:

  • Find more opportunities and win more business
  • Receive daily alerts for all new bid opportunities
  • Get contract opportunities matched to your business
ONE WEEK FREE TRIAL

See also

...Follow Government Publishing Office FY26 Equipment Inspection Active Contract Opportunity Notice... ID 040ADV-26-Q-0002 ...

UNITED STATES GOVERNMENT PUBLISHING OFFICE

Bid Due: 12/15/2026

...Notice 040ADV-26-R-0010 Department/Ind. Agency UNITED STATES GOVERNMENT PUBLISHING OFFICE Sub-tier... UNITED STATES GOVERNMENT ...

UNITED STATES GOVERNMENT PUBLISHING OFFICE

Bid Due: 7/06/2026

...Department/Ind. Agency UNITED STATES GOVERNMENT PUBLISHING OFFICE Sub-tier UNITED STATES GOVERNMENT... PUBLISHING OFFICE ...

UNITED STATES GOVERNMENT PUBLISHING OFFICE

Bid Due: 6/16/2026

...Directorate (AFDW/PK) are publishing this Request for Information post to conduct market research ...

DEPT OF DEFENSE

Bid Due: 6/10/2026

* Disclaimer: Information regarding bids, requests for proposals (RFPs), or requests for qualifications (RFQs) is provided on this website only for convenience and does not constitute official public notice. Persons wishing to respond to or inquire about bids, RFPs, or RFQs should contact the appropriate government department.